Parenteral Nutrition in Moderately Preterm, Otherwise Healthy Neonates Is Not Associated With Improved Short-Term

Pavel Prusakov1, Sunday Speaks1, Jacqueline S Magers1

  • 1Department of Pharmacy, Nationwide Children's Hospital, Columbus, Ohio, USA.

Insights

Early parenteral nutrition (PN) did not improve daily weight gain in moderately preterm infants (32-34 weeks gestation). These findings suggest PN supplementation is unlikely to benefit this specific infant population without major comorbidities.

Area of Science:

  • Neonatology
  • Pediatric Nutrition
  • Growth Monitoring

Background:

  • Parenteral nutrition (PN) is vital for extremely premature infants at risk of malnutrition.
  • Limited data exists on the effects of PN on short-term growth in moderately preterm infants.

Purpose of the Study:

  • To investigate the impact of early PN versus standard dextrose-containing fluids (DCFs) on daily weight gain in moderately preterm infants.
  • To evaluate secondary outcomes including time to regain birth weight, length of stay, and anthropometric changes.

Main Methods:

  • Retrospective cohort analysis of infants born at 32 to <34 weeks gestational age without major comorbidities.
  • Comparison of daily weight gain between infants receiving early PN and those receiving DCFs.
  • Analysis of secondary outcomes and clinical indicators like necrotizing enterocolitis and antibiotic use.

Main Results:

  • No significant difference in mean daily weight gain was observed between the PN and DCF groups (11.8 vs 10 g/kg/d, P = .09).
  • Weight gain from nadir to discharge also showed no significant difference (16.8 vs 15.2 g/kg/d, P = .1).
  • These results remained consistent even after propensity score matching.

Conclusions:

  • Neonates born at ≥32 weeks gestational age without major comorbidities are unlikely to experience benefits from early PN supplementation.
  • The study suggests standard care with DCFs may be sufficient for growth in this population.
Abstract

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
625
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
688
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
186
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
205
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
160